AMD3100 With Busulfan, Fludarabine and Thymoglobulin for Allogeneic Stem Cell Transplant for AML and MDS

NCT00396968 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Acute Myelogenous Leukemia
Myelodysplastic Syndromes

Interventions

DRUG: AMD3100
PROCEDURE: Allogeneic Stem Cell Transplantation

Sponsor

Genzyme, a Sanofi Company

Collaborators

[object Object]